✦ LIBER ✦

A Potential Novel Therapeutic Addition to Statin Therapy for Dyslipidemia

✍ Scribed by William B. Borden

Book ID: 107534311
Publisher: Current Science Inc.
Year: 2010
Tongue: English
Weight: 72 KB
Volume: 13
Category: Article
ISSN: 1523-3804
DOI: 10.1007/s11883-010-0144-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hypouricemic therapy: A novel potential

Hypouricemic therapy: A novel potential therapeutic option for nonalcoholic fatty liver disease

✍ Cheng-Fu Xu; Chao-Hui Yu; Lei Xu; Xiao-Ying Sa; You-Ming Li 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 1 views

We read with great interest the practice guidelines for the diagnosis and management of autoimmune hepatitis recently issued by the American Association for the Study of Liver Diseases (AASLD). 1 In particular, we appreciate the new definition of biochemical remission, which now requires not only no

A Review of the Rationale for Additional

A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough

✍ Jeffrey G. Shanes 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 135 KB

A novel exon 15-deleted, splicing varian

A novel exon 15-deleted, splicing variant of Slit2 shows potential for growth inhibition in addition to invasion inhibition in lung cancer

✍ Yu-Ying Lin; Chun-Hung Yang; Gwo-Tarng Sheu; Chi-Ying F. Huang; Yu-Chung Wu; Shu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB